Cite
HARVARD Citation
Willbold, D. et al. (n.d.). Clinical phase I data of the first orally available anti‐aβ‐prionic drug PRI‐002 that reverses behavioral and cognitive deficits, and decelerates neurodegeneration in AD animal models. Alzheimer's & dementia. p. n/a. [Online].